ACO Name & Location
Augusta Care Partners, LLC
78 Medical Center Drive
Fishersville, VA 22939
ACO Primary Contact
| Primary Contact Name | Clint Merritt |
| Primary Contact Phone Number | (540) 332-4818 |
| Primary Contact Email Address | CMerritt@augustahealth.com |
Organizational Information
ACO Participants
| ACO Participants | ACO Participant in Joint Venture (Enter Y or N) |
| Shenandoah Emergency Medicine Specialists LLC | N |
| Medical Center Women”s Health, Inc | N |
| Gerald Showalter | N |
| BLUE RIDGE FOOTCARE AND SURGERY PLC | N |
| Augusta Medical Group | N |
| BLUE RIDGE UROLOGICAL, PC | N |
| COMPREHENSIVE HEALTH SYSTEMS, PLC | N |
| VALLEY COMMUNITY SERVICES BOARD | N |
| Orthopedic Associates, Ltd (D/B/A Shenandoah Valley Orthopedics and Sports Medicine) | N |
| BLUE RIDGE PATHOLOGISTS PC | N |
| Augusta Health Care, Inc. | N |
| Eyeone, Plc | N |
| AUGUSTA SURGERY INC | N |
| SHENANDOAH VALLEY RADIATION ONCOLOGY ASSOCIATES, PC | N |
| AUGUSTA HEALTH CARE FOR WOMEN, PLC | N |
| GERALD SHOWALTER, PSY.D., PC | N |
| Staunton Eye Clinic PLC | N |
ACO Governing Body
Board of Managers
Member | Member’s Voting Power -Expressed as a percentage or number | Membership Type | ACO Participant Legal Business Name/DBA, if Applicable |
| Last Name | First Name | Title/Position |
| Otteni | Jack | Voting Member and Chair | 1 | ACO Participant Representative | Orthopedic Associates, Ltd (D/B/A Shenandoah Valley Orthopedics and Sports Medicine) |
| Snyder | John | Voting Member and Vice-Chair | 1 | ACO Participant Representative | Augusta Medical Group |
| Baroco | Patrick | Voting Member and Secretary/Treasurer | 1 | ACO Participant Representative | Augusta Medical Group |
| Fosnocht | David | Voting Member | 1 | ACO Participant Representative | Shenandoah Emergency Medicine Specialists, LLC |
| Just | Scott | Voting Member | 1 | ACO Participant Representative | Augusta Medical Group |
| Mannix | Mary | Voting Member | 1 | ACO Participant Representative | Augusta Health Care, Inc |
| Maybee | Nelly | Voting Member | 1 | ACO Participant Representative | Augusta Medical Group |
| Fenton | Barbara | Voting Member | 1 | Medicare Beneficiary Representative | |
Key ACO Clinical and Administrative Leadership
| ACO Executive | Clint Merritt, MD |
| Medical Director | Clint Merritt, MD |
| Compliance Officer | D. Scott Jones |
| Quality Assurance/Improvement Officer | Clint Merritt, MD |
Associated Committees and Committee Leadership
| Committee Name | Committee Leader Name and Position |
| Finance & Network Development | John Mattern, DO, Chair |
| Quality & Care Process | Stephanie Pitsilos, MD, Chair |
Types of ACO Participants or Combinations of Participants that Formed the ACO
- ACO professionals in a group practice arrangement
- Networks of individual practices of ACO professionals
- Partnerships or joint venture arrangements between hospitals and ACO professionals
Shared Savings and Losses
Amount of Shared Savings/Losses
- Third Agreement Period
- Performance year 2020, $1,967,858.08
- Second Agreement Period
- Performance Year 2019, $0
- Performance Year 2018, $0
- Performance Year 2017, $0
- Performance Year 2016, $0
- Performance Year 2015, $0
- Performance Year 2014, $0
Shared Savings Distribution
- Third Agreement Period
- Performance Year 2020
- Proportion invested in infrastructure: 10%
- Proportion invested in redesigned care processes/resources: 20%
- Proportion of distribution to ACO participants: 70%
- Second Agreement Period
- Performance Year 2019
- Proportion invested in infrastructure: N/A
- Proportion invested in redesigned care processes/resources: N/A
- Proportion of distribution to ACO participants: N/A
- Performance Year 2018
- Proportion invested in infrastructure: N/A
- Proportion invested in redesigned care processes/resources: N/A
- Proportion of distribution to ACO participants: N/A
- Proportion invested in infrastructure: N/A
- Proportion invested in redesigned care processes/resources: N/A
- Proportion of distribution to ACO participants: N/A
- Proportion invested in infrastructure: N/A
- Proportion invested in redesigned care processes/resources: N/A
- Proportion of distribution to ACO participants: N/A
- Proportion invested in infrastructure: N/A
- Proportion invested in redesigned care processes/resources: N/A
- Proportion of distribution to ACO participants: N/A
- Proportion invested in infrastructure: N/A
- Proportion invested in redesigned care processes/resources: N/A
- Proportion of distribution to ACO participants: N/A
Quality Performance Results
2020 Quality Performance Results
| ACO Quality Measure Number | Measure Name | Rate | ACO Mean |
| ACO-43 | Ambulatory Sensitive Condition Acute Composite (AHRQ Prevention Quality Indicator (PQI) #91) | 0.78 | 0.95 |
| ACO-13 | Falls: Screening for Future Fall Risk | 98.68 | 84.97 |
| ACO-14 | Preventive Care and Screening: Influenza Immunization | 86.16 | 76.03 |
| ACO-17 | Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention | 96.88 | 81.67 |
| ACO-18 | Preventive Care and Screening: Screening for Clinical Depression and Follow-up Plan | 90.33 | 71.46 |
| ACO-19 | Colorectal Cancer Screening | 84.29 | 72.59 |
| ACO-20 | Breast Cancer Screening | 88.72 | 74.05 |
| ACO-42 | Statin Therapy for the Prevention and Treatment of Cardiovascular Disease | 86.28 | 83.37 |
| ACO-27 | Diabetes Mellitus: Hemoglobin A1c Poor Control | 11.59 | 14.70 |
| ACO-28 | Hypertension (HTN): Controlling High Blood Pressure | 63.29 | 72.87 |
Please note, the ACO-40 Depression Remission at 12 months quality measure is not included in public reporting due to low sample size. The Centers for Medicare & Medicaid Services (CMS) also waived the requirement for ACOs to field a CAHPS for ACOs survey for PY 2020 through the Physician Fee Schedule Final Rule for Calendar Year 2021. Additionally, CMS reverted ACO-8 Risk-Standardized, All Condition Readmission and ACO-38 Risk-Standardized Acute Admission Rates for Patients with Multiple Chronic Conditions to pay-for-reporting, given the impact of the coronavirus disease 2019 (COVID-19) public health emergency (PHE) on these measures.
For Previous Years’ Financial and Quality Performance Results, please visit data.cms.gov.
Payment Rule Waivers
See “Fraud and Abuse Waivers” Tab
